Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. Joseph F. Lawler M.D., Ph.D. |
IPO Date | May 7, 2021 |
Location | United States |
Headquarters | 1415 Ranch Road 620 South, Lakeway, TX, United States, 78734 |
Employees | 2 |
Sector | Healthcare |
Industry | Biotechnology |
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.
NA
NA
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email